With key tax credit under microscope, biotech firms say it should stay, be improved
But not everyone is happy with the SR&ED program. Critics say it’s ineffective and complicated.
Paul Lem, CEO and founder of the Ottawa-based biotechnology company Spartan Bioscience, has gotten back millions of dollars from the SR&ED tax-credit program over the years. The Hill Times photograph by Sam Garcia